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ABSTRACT
Objective: The present study was carried out to evaluate the ulceroprotective effect of ethanolic extract of leaves of Moringa oleifera (EEMO) on 
experimentally induced inflammatory bowel disease (IBD) on Albino (Wistar strain) rats.
Methods: The rats were divided into four groups of six animals each. Group A and Group B received gum acacia per orally (P.O.), Group C received 
EEMO in dose of 500 mg/kg/day P.O., and Group D received 5-aminosalicylic acid (5-ASA) in the dose of 100 mg/kg/day P.O. All the animals were 
pre-treated with respective drugs (volume of drugs was kept constant at 10 ml/kg) for 5 days, along with the normal diet. On 5th day, animals were 
kept fasting for 12 h (overnight), and IBD was induced next morning in Groups B, C, and D by the administration of 1 ml of 4% acetic acid solution 
transrectally (TR). Group A (normal control) received 0.9% normal saline TR instead.
Results: The results have been shown that EEMO has significant activity against experimentally induced IBD when compared to the experimental 
control, with near normalization of colon architecture both macroscopically as well as microscopically. Tissue oxidative stress was reduced with 
significant improvement in tissue levels of superoxide dismutase (SOD) and catalase (CAT). Furthermore, significant improvement in levels of 
myeloperoxidase (MPO) was observed.
Conclusion: It is concluded that EEMO has got potent activity against experimentally induced IBD due to its anti-inflammatory and antioxidant 
properties.
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INTRODUCTION
IBD is a disorder characterized by chronic inflammation of the 
gastrointestinal tract. There are two clinical subtypes: Ulcerative 
colitis (UC) and Crohn’s disease (CD). UC is limited to the colon (large 
intestine), while CD can involve any part of the gastrointestinal tract 
from mouth to anus, and it most commonly affects the small intestine 
and/or the colon [1]. The IBD is associated with colon cancer [2].
Despite the fact that a number of theories have been proposed to describe 
the causative agent in IBD, still, the etiology of IBD remains unknown. 
Clinical, epidemiological, and experimental studies have been used to 
attempt to elucidate the etiology of IBD. A number of factors, including 
genetic, microbial, viral, immunological, nutritional, thrombosis, and 
environmental agents, have been implicated in the pathogenesis of IBD [3]. 
Neutrophil infiltration in the extravascular space involves a complex 
sequence of interaction between circulating neutrophils and the vascular 
endothelium, including rolling, adhesion, and transendothelial migration. 
MPO is an enzyme mainly found in azurophilic granules of neutrophils. 
It is a good marker of neutrophil infiltration in gastrointestinal tissues, 
as well as inflammation and tissue injury. Besides, significant amounts 
of superoxide can be generated by a variety of endogenous enzyme 
systems such as the peroxisomal enzyme xanthine oxidase (XO) following 
tissue ischemia. XO activity is often increased in intestinal inflammation 
through the induction by tumor necrosis factor-alpha and activated 
neutrophils [4]. It has been suggested that XO is a significant source 
of superoxide in the inflammation of IBD [5]. The concentrations of 
endogenous antioxidants such as reduced glutathione, alpha-tocopherol, 
and cysteine are all significantly decreased in IBD patients. As a result, 
the balance between antioxidants and reactive oxygen metabolites 
becomes seriously impaired [6]. A population-based study performed in 
India for UC shows a prevalence rate of 44.3/100,000 inhabitants and an 
incidence rate of 6.02 cases/100,000 inhabitants [7].
The evaluation of various plant products according to their traditional 
uses and medicinal value based on their therapeutic efficacy leads to 
the discovery of newer and recent drugs for treating various ailments. 
This fact forms the basis for the development of new drugs from various 
plant sources. One of such plants of medicinal value is M. oleifera [8].
M. oleifera Lam. (Drumstick tree) a plant in a family of Moringaceae is 
widely cultivated in India, used as food and active ingredient of the food 
preparation, medication, and oil manufacturing. Almost, all parts of the 
plant have been utilized in traditional medical practices. It is believed 
to be a miracle herb because it can be used as food as well as medicine 
for numerous ailments. The leaves and young buds of the plant are used 
as a vegetable and can be rubbed on the temples for relieving headache, 
while the root and root bark are regarded as antiscorbutic and can be 
externally used as counter-irritants. The juice of leaves mixed with 
honey is used for the treatment of eye diseases. The leaves of the plants 
have also been reported or its antitumor, hypotensive, antioxidant, 
radioprotective, anti-inflammatory, and diuretic properties [9].
METHODS
This study has been approved by the IEAC, Assam Medical College, 
Dibrugarh, Certificate no. being AMC/EC/PG/2011/11517 dated 
06/09/2011.
Plant authentication
Fresh tender leaves of M. oleifera approximately 1 kg, collected in the 
year 2010, were used for the study. The plant was authenticated by 
© 2019 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2019.v12i8.34227
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Dr. M. Islam, Professor of Life Science, Dibrugarh University, Dibrugarh, 
Assam, India (Voucher No. 05).
Preparation of plant extract
An amount of 180 g of dried powder was obtained, and 95% ethanol 
was added to the powdered drug in sufficient amount to render it 
evenly and distinctly damped. The entire solution was transferred to 
a percolator and to its sufficient amount of 95% of ethanol was added. 
The top of the percolator was closed, and when liquid was about to drip 
from the apparatus, the lower orifice of the percolator was also closed, 
and the solution was allowed to macerate for 24 h at room temperature. 
After 24 h of maceration, percolation was allowed slowly at the rate not 
exceeding 1 ml/min [10]. The residue thus obtained was collected in 
glass Petri dishes and allowed to evaporate at room temperature. When 
completely dried, the extract was scrapped out, weighed, and stored for 
further use. The yield at the end of extraction was 16 g.
Animals
The study was conducted on male and female healthy Albino Wistar 
rats weighing 150–250 g. The animals were obtained from the Central 
Animal House, Assam Medical College, Dibrugarh. The rats were housed 
in polypropylene cages and maintained under standard conditions 
(12 h light/dark cycle, at room temperature 25°C ± 3°C and 35%–60% 
humidity). The rats were maintained on standard animal diet of Bengal 
gram, wheat, maize and carrot in sufficient quantity for the entire 
period of the experiment. Water was given ad libitum during the entire 
period of the experiment. The study was approved by the Institutional 
Animal Ethics Committee, AMC. The albino rats were maintained and 
followed under the good laboratory practices and the guidelines of 
Committee for the Purpose of Control and Supervision on Experiments 
on Animals [11].
Induction of experimental IBD
For induction of IBD, a soft pediatric catheter was advanced 6 cm from 
the anus under low-dose ether anesthesia. Rats were in Trendelenburg 
position during this process, and 1 ml of 4% acetic acid or 0.9% NS 
solution was slowly administered TR. The rats were maintained in 
head-down position for 30 s to prevent leakage, and the rest of the 
solution was aspirated. After this process, 2 ml of a phosphate buffer 
solution with pH 7 was administered TR. All the animals were sacrificed 
after 48 h of IBD induction by ether overdose. The abdomen was 
opened and colon was exposed. Distal 8 cm of colon was excised and 
opened by a longitudinal incision. After washing the mucosa with saline 
solution, the mucosal injury was assessed macroscopically using scale 
of Morris et al. [12,13]. Disease activity index (DAI) was also measured, 
the ratio of colon weight to body weight, which was used as a parameter 
to assess the degree of tissue edema and reflects the severity of colonic 
inflammation. A 6–8 mm sample block of the inflamed colonic tissue 
with the full thickness was excised from a region of grossly visible 
damage for histological analysis. Formalin-fixed tissue samples were 
embedded in paraffin and stained with hematoxylin and eosin stain. 
Colonic tissues were scored for histological damage using the criteria 
of Wallace and Keenan. After scoring colonic tissue samples were 
homogenized with 10 volumes of ice-cold 0.25 M sucrose, centrifuged 
at 14,000 rpm to measure the biochemical parameters in resulting 
supernatant [3].
Biochemical assessments
Myeloperoxidase (MPO) activity, superoxide dismutase (SOD) level, 
and Catalase (CAT) level. The above parameters were measured using 
double beam UV-spectrophotometer [14,15].
Acute oral toxicity test in rats
After overnight fasting of rats, EEMO was given orally in doses of 50, 
100, 200, 500, and maximum dose of 1000 mg/kg body weight and 
observed carefully for the first 2–3 h for signs of toxicity. The behavioral 
changes and percentage mortality were documented beginning with 
24 h up to a period of 14 days [16].
Experimental design
Twenty four healthy Wistar albino rats weighing 150–200 g were used 
in the study and divided into four groups with six animals in each group 
as follows:
1. Group A (normal control) received 3% gum acacia 10 ml/kg/day, P. O.
2. Group B (experimental control) received 3% gum acacia10 ml/kg/day, P.O.
3. Group C (test) received EEMO 500 mg/kg/day, P.O.
4. Group D (standard) received 5-ASA acid 100 mg/kg/day, P.O.
All the animals were pre-treated with respective drugs (volume of 
drugs was kept constant at 10 ml/kg) for 5 days, along with the normal 
diet. On 5th day, animals were kept fasting for 12 h (overnight), and IBD 
was induced next morning in Groups B, C, and D by the administration 
of 1 ml of 4% acetic acid solution TR. Group A (normal control) received 
0.9% normal saline TR instead.
Statistical analysis
Data were calculated as the mean ± standard error of mean (SEM). 
Statistical analysis was performed using SPSS (IBM SPSS Statistics 
Version 20.0). The values were analyzed using one-way analysis of 
variance (ANOVA), followed by post hoc  Dunnett’s multiple comparison 
tests. The results were considered to be significant when p<0.05.
RESULTS
Acute toxicity study
Acute toxicity study showed that no signs of toxicity, behavioral changes, 
and mortality were there up to a dose of 1000 mg/kg body weight of the 
acute toxicity estimate.
Effect on IBD-induced rats
Normal control
Group A, normal control, showed normal mucosal architecture 
macroscopically and microscopically (Table 1, Figs. 1a and 2).











A (normal control) 0.33±0.21a,d 0.51±0.02a,d 0±0a,c 400.6±1.9a,c 6.9±0.33a,c 0.31±0.01a,c
B (experimental control) 4.6±0.25c 1.8±0.02c 4.8±0.20c 148.3±0.33c 3.4±0.24c 3.8±0.04c
C (EEMO) 3.2±0.20a,c 0.86±0.01a,c 0.55±0.24a,c 306.6±1.03a,c 5.2±0.32a,c 2.3±0.04a,c
D (5-ASA) 2.4±0.25a 0.74±0.06a 2.4±0.24a 304.9±9.23a 360.8±0.71a 1.2±0.02a
AF 50.26 28.29 70.37 250.8 28.44 333.4
Ndf
O
20, 3 20, 3 20, 3 20, 3 20, 3 20, 3
VP
A
<0.05 <0.05 <0.05 <0.05 <0.05 <0.05
Values are expressed as mean±SEM, n=6. ap<0.05 and bp>0.05 when compared to experimental control; cp<0.05 and dp>0.05 when compared to 5-ASA; ANOVA followed 
by Dunnett’s t-test. DAI: Disease activity index, ANOVA: Analysis of variance, SEM: Standard error of mean, 5-ASA: 5-aminosalicylic acid, EEMO: Ethanolic extract of 
leaves of Moringa oleifera, CAT: Catalase, SOD: Superoxide dismutase, MPO: Myeloperoxidase
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Acetic acid
Acetic acid administration to the experimental control group caused 
significant macroscopic ulcerations and inflammations in the rat colon 
along with significant mucosal injury microscopically, when compared 
to the normal control group (p<0.05). Furthermore, there was a 
significant derangement of biochemical parameters including tissue 
levels of MPO, SOD, and CAT (p<0.05) showing oxidative stress due to 
colon damage and colonic inflammation (Table 1, Figs. 1b and 2).
EEMO
EEMO showed significant activity against experimentally induced 
IBD when compared to the experimental control (p<0.05) with 
near normalization of colon architecture both macroscopically and 
microscopically. Tissue oxidative stress was reduced with significant 
improvement in tissue levels of SOD and CAT (p<0.05). Furthermore, 
significant improvement in levels of MPO was observed (p<0.05) 
(Table 1, Figs. 1c and 2).
5-ASA
As for the standard drug 5-ASA, its activity against IBD was significantly 
greater than EEMO with regard to all parameters (p<0.05). When 
compared to the normal control, 5-ASA showed near normalization 
of DAI and macroscopic score, as there was no significant difference 
between normal control group and 5-ASA group (p>0.05) (Table 1, 
Figs. 1d and 2).
DISCUSSION
The results showed that EEMO has got a good potential to suppress 
experimental colitis in rats, as indicated by macroscopic, microscopic, 
and biochemical evaluations.
Colitis is a term used to describe inflammation of the colon, which leads 
to various changes in the colonic histological organization [17].
Acetic acid-induced colitis model is similar to human UC in terms of 
histological features. It affects the distal colon portion and induces non-
transmural inflammation, massive necrosis of mucosal and submucosal 
layers, mucosal edema, and neutrophil infiltration of the mucosa and 
submucosal ulceration. The protonated form of the acid liberates protons 
within the intracellular space and causes massive intracellular acidification 
resulting in massive epithelial damage. Inflammation is the pathogenesis 
of IBD and several pathways are associated with inflammatory response 
in IBD. The inflammatory response initiated by acetic acid includes 
activation of cyclooxygenase and lipoxygenase pathways [18].
Oxidative stress is believed to play a key role in the pathogenesis of 
IBD-related intestinal damage. As a matter of fact, intestinal mucosal 
damage in the IBD, including CD and UC, is related to both increased 
free radical production and to a low concentration of endogenous 
antioxidant defense [19].
As proved by the above study and also described in literature, leaves 
extract of M. oleifera possesses significant anti-oxidant property, 
proving its role in the management of experimentally induced IBD.
CONCLUSION
It can be concluded from the study that ethanol extract of leaves of 
M. oleifera has got potent activity against experimentally induced IBD 
due to its anti-inflammatory and antioxidant properties; still, it is to be 
further investigated for its clinical utility.
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